Surgery and Actinomycin Improve Survival in Malignant Rhabdoid Tumor
Figure 5
Kaplan-Meier survival estimates of patients treated with and without actinomycin. Actinomycin is associated with a 74% reduced risk of death () which held true for all age groups.
